Family Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-2,733
| Closed | -$88K | – | 79 |
|
|
2016
Q4 | $88K | Buy |
2,733
+572
| +26% | +$18.4K | 0.06% | 62 |
|
|
2016
Q3 | $108K | Buy |
2,161
+382
| +21% | +$19.1K | 0.06% | 74 |
|
|
2016
Q2 | $75K | Buy |
+1,779
| New | +$75K | 0.04% | 77 |
|
|
2016
Q1 | – | Sell |
-1,525
| Closed | -$95K | – | 85 |
|
|
2015
Q4 | $95K | Sell |
1,525
-254
| -14% | -$15.8K | 0.05% | 74 |
|
|
2015
Q3 | $119K | Buy |
+1,779
| New | +$119K | 0.05% | 90 |
|
|
2015
Q2 | – | Sell |
-2,606
| Closed | -$244K | – | 110 |
|
|
2015
Q1 | $244K | Sell |
2,606
-1,525
| -37% | -$143K | 0.11% | 74 |
|
|
2014
Q4 | $367K | Buy |
4,131
+1,653
| +67% | +$147K | 0.17% | 64 |
|
|
2014
Q3 | $171K | Buy |
2,478
+699
| +39% | +$48.2K | 0.08% | 86 |
|
|
2014
Q2 | $102K | Hold |
1,779
| – | – | 0.05% | 80 |
|
|
2014
Q1 | $71K | Hold |
1,779
| – | – | 0.04% | 73 |
|
|
2013
Q4 | $75K | Buy |
+1,779
| New | +$75K | 0.04% | 66 |
|